Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Objective: Determine the safety and efficacy of GM-CSF inhalation in patients with aPAP.
Study Design: multi-center, randomized, double-blind, placebo- controlled, safety/efficacy
study.